EN
HI
Dr Lal Pathlabs. Share price
LALPATHLAB
1887.2
14.20 (-0.75%)NSE
BSE
Last updated on 19 Aug, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Dr Lal Pathlabs share price chart
Dr Lal Pathlabs. Share Key Metrics
Volume
1.57 L
Market Cap
31636.60 CR
LTQ@LTP
1@1887.20
ATP
1886.62
Var Margin
15.35 %
Circuit Range
1521.2-2281.6
Delivery %
53.97 %
Value
29.54 CR
ASM/GSM
No
Market Lot
1
Summary
LALPATHLAB stock price is ₹1887.2 as of 19 Aug, 2026. The stock intraday movement has stayed between ₹1877.30 and ₹1903.70, while Dr Lal Pathlabs. share price 52 week high low is ₹1272.60 & ₹1988.90.
In terms of trading activity, LALPATHLAB share price has recorded a volume of 1,56,564 shares. The Dr Lal Pathlabs. has a market cap of ₹167637770. The stock’s Average Traded Price (ATP) stands at ₹1886.62, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1887.20.
The Dr Lal Pathlabs. upper circuit limit is ₹2281.60 & The Dr Lal Pathlabs. lower circuit limit is ₹1521.20, with a Value of ₹29.54 CR. The Delivery Percentage for the day is 53.97%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Dr Lal Pathlabs. Resistance and Support
Pivot 1895.8
Resistance
First Resistance
1917.6
Second Resistance
1933.8
Third Resistance
1955.6
Support
First Support
1879.6
Second Support
1857.8
Third Support
1841.6
Dr Lal Pathlabs. Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
53.19%
Mutual Fund
18.79%
Insurance
2.37%
Foreign Institutional Investors
17.35%
Domestic Institutional Investors
0.31%
Retail
7.99%
Others
0%
Total Promoters
MAR '26
53.21%
JUN '26
53.19%
Dr Lal Pathlabs. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-24 | Quarterly Results |
| 2026-04-30 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results & Interim Dividend |
| 2025-10-31 | Qtr Results |
| 2025-07-31 | Quarterly Results |
| 2025-04-25 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-23 | Quarterly Results & Interim Dividend |
| 2024-08-07 | Quarterly Results & Interim Dividend |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-30 | 2026-07-30 | View More |
| Bonus Date | Record Date | |
|---|---|---|
| 2025-10-31 | 2025-12-19 | View More |
Dr Lal Pathlabs. News
Dr. Lal PathLabs Ltd - 539524 - Incorporation Of A Step-Down Subsidiary Company
Dr. Lal Path Labs' wholly owned subsidiary, Dr Lal PathLabs FZCO, Dubai, incorporated a new step-down subsidiary named 'Dr Lal PathLabs Indomed LLC' in Tashkent, Uzbekistan. This entity will hold 70% of its share capital and will provide diagnostic services, strengthening the group's presence in the region.
Aug 19 2026 18:24:04
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dr. Lal Path Labs announced strong Q1 FY27 consolidated financial results, with revenue growing 19.1% to Rs.798 cr and net profit increasing 27.2% to Rs.170 cr. The company also declared an interim dividend of Rs.5 per share.
Jul 24 2026 14:17:40
Dr. Lal PathLabs Ltd - 539524 - Corporate Action-Board approves Dividend
Dr. Lal Path Labs declared an interim dividend of ₹5 per equity share for FY27. The record date for this dividend is July 30, 2026, with payment due within 30 days.
Jul 24 2026 13:57:05
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Acquisition
Dr. Lal Path Labs' subsidiaries acquired stakes in two companies: 80% in Ghana's Sunshine Healthcare for Rs.38 Cr to expand presence in West Africa, and 30% in India's Neuome Technologies for Rs.3.5 Cr to gain access to innovative bio-banking solutions.
Jul 24 2026 13:51:16
Dr. Lal PathLabs Ltd - 539524 - Grant Of Stock Options
Dr. Lal Path Labs Board of Directors met on July 24, 2026, approving the unaudited financial results for Q1 FY27. The Board also declared an interim dividend of Rs. 5 per equity share for FY 2026-27, with July 30, 2026, set as the record date.
Jul 24 2026 13:49:15
Dr. Lal PathLabs Ltd - 539524 - The Record Date For The Purpose Of Payment Of Interim Dividend Shall Be July 30, 2026
Dr. Lal Path Labs announced an interim dividend of ₹5 per equity share for FY2026-27. The record date for this dividend is fixed as July 30, 2026, with payment expected within 30 days of declaration.
Jul 24 2026 13:47:07
Dr. Lal PathLabs Ltd - 539524 - Board Meeting Outcome for Outcome Of Board Meeting - July 24, 2026
Dr. Lal Path Labs reported Q1 FY27 consolidated revenue of ₹797.7 crore and net profit of ₹170.5 crore. The company also declared an interim dividend of ₹5 per equity share with July 30, 2026 as the record date. Additionally, it approved the acquisition of 80% stake in Sunshine Healthcare Ltd, Ghana for ₹38 crore and 30% stake in Neuome Technologies Pvt Ltd, India for ₹3.5 crore.
Jul 24 2026 13:42:34
Read More
Dr Lal Pathlabs. Management
| Name | Position |
|---|---|
| Vinay Gujral | Company Secretary & Compliance Officer |
| Arvind Lal | Chairman |
Dr Lal Pathlabs. Similar Stocks
Global Health Ltd.
1417.20
-25.50 (1.77%)
Narayana Hrudayalaya Ltd.
1785.70
-17.30 (0.96%)
Emcure Pharmaceuticals Ltd.
1891.00
16.50 (0.88%)
Krishna Institute of Medical Sciences Ltd
788.65
-16.85 (2.09%)
Wockhardt Ltd.
1826.00
-33.90 (1.82%)
Neuland Laboratories Ltd.
23290.00
-80.00 (0.34%)
Sai Life Sciences Ltd.
1422.20
-17.90 (1.24%)
Piramal Pharma Ltd.
209.64
-0.89 (0.42%)
Acutaas Chemicals Ltd.
3228.90
-162.50 (4.79%)
Dr Lal Pathlabs. FAQs
The Buying Price of Dr Lal Pathlabs. share is 1887.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Dr Lal Pathlabs. stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Dr Lal Pathlabs., choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Dr Lal Pathlabs. shares is 58.86. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Dr Lal Pathlabs. shares is 12.21. Useful to assess the stock's value relative to its book value.
To assess Dr Lal Pathlabs.’s valuation compare Sector P/E, P/B which are 49.4 & -14.54 with sector averages, along with growth rates and financial metrics.
The Market Cap of Dr Lal Pathlabs. is 31636.60 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Dr Lal Pathlabs. share price is 1988.90 & 1272.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Dr Lal Pathlabs. belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in LALPATHLAB
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in LALPATHLAB
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade